Abdominal fat analyzed by DEXA scan reflects visceral body fat and improves the phenotype description and the assessment of metabolic risk in mice. Am J Physiol Endocrinol Metab 303: E635-E643, 2012. First published July 3, 2012 doi:10.1152/ajpendo.00078.2012Clinical studies have demonstrated a strong relationship between visceral fat content and metabolic diseases, such as type 2 diabetes and liver steatosis. Obese mouse models are an excellent tool to study metabolic diseases; however, there are limited methods for the noninvasive measurement of fat distribution in mice. Although micromagnetic resonance imaging and microcomputed tomography are the "gold standards" in the measurement of fat distribution, more economical and accessible methods are required. Dual energy X-ray absorptiometry (DEXA) is an effective method in characterizing fat content; however, it cannot discriminate between visceral and subcutaneous fat depots. We demonstrate that an evaluation of abdominal fat content measured by DEXA through the selection of one localized abdominal area strongly correlates with visceral fat content in C57BL/6J mice. We found that DEXA is able to measure fat pad volume ex vivo with high accuracy; however, the measurement of visceral fat in vivo shows an overestimation caused by subcutaneous tissue interference. The overestimation is almost constant for a wide range of values, and thus it is possible to correct the data for a more accurate estimation of visceral fat content. We demonstrate the utility of this technique in characterizing phenotypes of several obese mouse models (ob/ob, db/db, MC4R-KO, and DIO) and evaluating the effect of treatments on visceral fat content in longitudinal studies. Additionally, we also establish abdominal obesity as a potential biomarker for metabolic abnormalities (liver fat accumulation, insulin resistance/ diabetes) in mice, similar to that described in humans. dual-energy X-ray absorptiometry scan; metabolic diseases; glucose tolerance test; fat distribution ADIPOSE TISSUE IS NOT DISTRIBUTED UNIFORMLY in the body; instead, it accumulates in specific compartments as either visceral adipose tissue (VAT) or subcutaneous adipose tissue (SAT). Anatomically distinct body fat depots have unique metabolic properties (30). VAT has proatherogenic and prothrombic characteristics (35). VAT also has relatively more capillaries and efferent sympathetic axons per unit of volume than SAT (39). Visceral adipocytes exhibit increased production of inflammatory mediators such as tumor necrosis factor-␣, interleukins, and other cytokines but secrete less leptin and adiponectin than SAT (36). It has also been shown that insulin effect (antilipolytic) is lower and catecholamine effect (lipolytic) higher in VAT, enabling visceral fat to release free fatty acids more extensively. More importantly, due to its anatomic position, secretions from visceral adipocytes have easy access to the liver through the portal system (2).Body composition measurement and fat distribution are important to study and unde...